Jul 24, 2012
Whole Genome Sequencing Study Provides Key Insight Into Human Evolution and Origin of Short Stature
New data published in journal Cell shows Complete Genomics’ sequencing data enabled the discovery of 5 million new genetic variants and, likely, a new hominin ancestor
MOUNTAIN VIEW, Calif. – July 26, 2012 – Complete
Jul 11, 2012
Complete Genomics Announces New Technology Developed to Set Standard for Clinical-Grade Genomes
Long Fragment Read Technology Described in Nature Paper Provides Much Higher Accuracy Sequencing
MOUNTAIN VIEW, Calif. – July 11, 2012 – Complete Genomics, Inc. (NASDAQ: GNOM) today announced that its Long Fragment Read (LFR) technology for whole genome
May 9, 2012
Whole Genome Sequencing in Type 2 Diabetes Genetic Study
Complete Genomics sequencing data may help researchers discover new rare type 2 diabetes genetic variants in Mexican-American families
MOUNTAIN VIEW, Calif. – May 9, 2012 – Complete Genomics Inc. (NASDAQ: GNOM) announced today that it has sequenced the genomes of 600
May 8, 2012
Complete Genomics Builds Asia-Pacific Presence, Signs Distributor Agreements in Australia, China, Japan and Korea
New Distributors Will Ship DNA Samples to Complete Genomics for Sequencing
MOUNTAIN VIEW, Calif. – May 8, 2012 – Complete Genomics Inc. (NASDAQ: GNOM), the whole human genome sequencing company, today announced that it has signed
Mar 29, 2012
Complete Genomics Now Accepts DNA Obtained From Saliva for Whole Human Genome Sequencing
Further expansion of service offerings and collaboration with DNA Genotek allows more researchers with saliva samples access to highly accurate sequencing data
MOUNTAIN VIEW, Calif. – March 29, 2012 – Complete Genomics Inc. (NASDAQ: GNOM) has begun
The company, which was established in March 2006, has been operating in “stealth mode” from a 32,000 sq. ft. facility near San Francisco, California. For the past 2.5 years, Complete Genomics has been reinventing the process of DNA sequencing based on pioneering technology invented by its founders and refined by a team of 100 employees with expertise in DNA engineering, molecular biology, instrumentation, semiconductors and high-performance computing.